AP2001002207A0 - Antiviral nucleoside analogues. - Google Patents

Antiviral nucleoside analogues.

Info

Publication number
AP2001002207A0
AP2001002207A0 APAP/P/2001/002207A AP2001002207A AP2001002207A0 AP 2001002207 A0 AP2001002207 A0 AP 2001002207A0 AP 2001002207 A AP2001002207 A AP 2001002207A AP 2001002207 A0 AP2001002207 A0 AP 2001002207A0
Authority
AP
ARIPO
Prior art keywords
nucleoside analogues
antiviral nucleoside
antiviral
analogues
useful
Prior art date
Application number
APAP/P/2001/002207A
Other languages
English (en)
Inventor
Nghe Nguyen-Ba
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Publication of AP2001002207A0 publication Critical patent/AP2001002207A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
APAP/P/2001/002207A 1998-12-23 1999-12-22 Antiviral nucleoside analogues. AP2001002207A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11379798P 1998-12-23 1998-12-23
PCT/CA1999/001229 WO2000039143A2 (en) 1998-12-23 1999-12-22 Antiviral nucleoside analogues

Publications (1)

Publication Number Publication Date
AP2001002207A0 true AP2001002207A0 (en) 2001-09-30

Family

ID=22351590

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002207A AP2001002207A0 (en) 1998-12-23 1999-12-22 Antiviral nucleoside analogues.

Country Status (27)

Country Link
US (3) US6358963B1 (enExample)
EP (1) EP1140937B1 (enExample)
JP (1) JP2002533470A (enExample)
KR (1) KR100653485B1 (enExample)
CN (1) CN1117751C (enExample)
AP (1) AP2001002207A0 (enExample)
AT (1) ATE254126T1 (enExample)
AU (1) AU760875B2 (enExample)
BR (1) BR9916849A (enExample)
CA (1) CA2355712C (enExample)
CZ (1) CZ20012352A3 (enExample)
DE (1) DE69912842T2 (enExample)
DK (1) DK1140937T3 (enExample)
EA (1) EA004767B1 (enExample)
ES (1) ES2209532T3 (enExample)
HU (1) HUP0104827A3 (enExample)
ID (1) ID30477A (enExample)
IL (1) IL143867A0 (enExample)
MX (1) MXPA01006425A (enExample)
NO (1) NO20013163L (enExample)
NZ (1) NZ513094A (enExample)
OA (1) OA11741A (enExample)
PT (1) PT1140937E (enExample)
TR (1) TR200102501T2 (enExample)
UY (1) UY25878A1 (enExample)
WO (1) WO2000039143A2 (enExample)
ZA (1) ZA200105702B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143867A0 (en) * 1998-12-23 2002-04-21 Shire Biochem Inc Antiviral nucleoside analogues
CA2399062C (en) 2000-02-11 2010-01-12 Shire Biochem Inc. Stereoselective synthesis of nucleoside analogues
WO2004009595A1 (en) * 2002-07-03 2004-01-29 Triangle Pharmaceuticals, Inc. Combination therapy with 1,3-dioxolanes and inosine monophosphate dehydrogenase inhibitors
ES2360096T3 (es) 2002-08-06 2011-05-31 Pharmasset, Inc. Procedimientos de preparación de nucleosidos de 1,3-dioxolano.
US7706405B2 (en) * 2002-09-12 2010-04-27 Interdigital Technology Corporation System for efficient recovery of Node-B buffered data following MAC layer reset
CA2505552C (en) 2002-11-18 2012-06-05 Shire Biochem Inc. Stereoselective process for the production of dioxolane nucleoside analogues
DE10335061B4 (de) * 2003-07-31 2005-11-17 Wacker-Chemie Gmbh Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
CA2554782C (en) * 2004-02-03 2013-08-13 Emory University Methods to manufacture 1,3-dioxolane nucleosides
US7322412B2 (en) * 2004-08-30 2008-01-29 Halliburton Energy Services, Inc. Casing shoes and methods of reverse-circulation cementing of casing
ES2369619T3 (es) * 2008-03-20 2011-12-02 Befesa Salzschlacke Gmbh Materia prima con alto contenido en arcilla de aluminio y método para su fabricación.
WO2012048455A1 (zh) * 2010-10-12 2012-04-19 武汉大学 一种抗病毒透皮吸收贴片及其制备方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041037A (en) 1975-06-10 1977-08-09 American Home Products Corporation Antitumor derivatives of periodate-oxidized cytidine
US4000137A (en) 1975-06-10 1976-12-28 American Home Products Corporation Antitumor derivatives of periodate-oxidized nucleosides
JPS5668674A (en) 1979-11-08 1981-06-09 Shionogi & Co Ltd 5-fluorouracil derivative
JPS5738774A (en) 1980-08-19 1982-03-03 Chugai Pharmaceut Co Ltd Uracil derivative and its preparation
US4479942A (en) 1981-08-10 1984-10-30 Fujisawa Pharmaceutical Co., Ltd. Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
HU198933B (en) 1987-11-02 1989-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new xanthine derivatives and pharmaceutical compositions comprising same as active ingredient
US5041449A (en) 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
NZ228645A (en) * 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
CA2152269C (en) 1989-02-08 1999-09-21 Bernard Belleau (Deceased) Process for preparing substituted 1,3-oxathiolanes with antiviral properties
US5270315A (en) 1988-04-11 1993-12-14 Biochem Pharma Inc. 4-(purinyl bases)-substituted-1,3-dioxlanes
US4987224A (en) 1988-08-02 1991-01-22 University Of Georgia Research Foundation, Inc. Method of preparation of 2',3'-dideoxynucleosides
PT95516A (pt) * 1989-10-06 1991-08-14 Wellcome Found Processo para a preparacao de derivados de 2',3'-didesoxi nucleosidos 6-substituidos
US5914331A (en) 1990-02-01 1999-06-22 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5276151A (en) 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5700937A (en) 1990-02-01 1997-12-23 Emory University Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
DK0560794T3 (da) 1990-11-13 1996-12-23 Iaf Biochem Int Substituerede 1,3-oxathiolaner med antivirale egenskaber
US5925643A (en) 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
US5179104A (en) 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
WO1992010496A1 (en) 1990-12-05 1992-06-25 University Of Georgia Research Foundation, Inc. ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES
US5444063A (en) 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
IL100965A (en) 1991-02-22 1999-12-31 Univ Emory 2-Hydroxymethyl-5-(5-fluorocytosin-l-yl)-1,3-oxathiolane its resolution and pharmaceutical compositions containing it
WO1992018517A1 (en) 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
GB9109506D0 (en) 1991-05-02 1991-06-26 Wellcome Found Therapeutic nucleosides
GB9110874D0 (en) 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923640B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9200150D0 (en) 1992-01-06 1992-02-26 Wellcome Found Therapeutic nucleosides
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
GB9525606D0 (en) * 1995-12-14 1996-02-14 Iaf Biochem Int Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
US5792773A (en) 1996-11-15 1998-08-11 Yale University L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection
IL143867A0 (en) * 1998-12-23 2002-04-21 Shire Biochem Inc Antiviral nucleoside analogues

Also Published As

Publication number Publication date
EP1140937A2 (en) 2001-10-10
TR200102501T2 (tr) 2002-01-21
MXPA01006425A (es) 2002-06-04
US20010049372A1 (en) 2001-12-06
CN1117751C (zh) 2003-08-13
WO2000039143A2 (en) 2000-07-06
DE69912842D1 (de) 2003-12-18
ID30477A (id) 2001-12-13
HUP0104827A3 (en) 2002-08-28
CA2355712C (en) 2009-03-17
KR100653485B1 (ko) 2006-12-04
AU1765700A (en) 2000-07-31
ATE254126T1 (de) 2003-11-15
CA2355712A1 (en) 2000-07-06
NO20013163D0 (no) 2001-06-22
US6358963B1 (en) 2002-03-19
US6545001B2 (en) 2003-04-08
JP2002533470A (ja) 2002-10-08
NZ513094A (en) 2004-05-28
HUP0104827A2 (en) 2002-06-29
KR20020013485A (ko) 2002-02-20
DE69912842T2 (de) 2004-05-13
ZA200105702B (en) 2002-10-11
IL143867A0 (en) 2002-04-21
NO20013163L (no) 2001-08-20
EP1140937B1 (en) 2003-11-12
ES2209532T3 (es) 2004-06-16
CZ20012352A3 (cs) 2001-10-17
US20040058893A1 (en) 2004-03-25
AU760875B2 (en) 2003-05-22
BR9916849A (pt) 2001-10-30
WO2000039143A3 (en) 2000-11-02
EA200100711A1 (ru) 2001-12-24
OA11741A (en) 2005-05-13
CN1334814A (zh) 2002-02-06
PT1140937E (pt) 2004-04-30
UY25878A1 (es) 2001-08-27
EA004767B1 (ru) 2004-08-26
DK1140937T3 (da) 2004-03-22

Similar Documents

Publication Publication Date Title
DK1280813T3 (da) Antivirale pyrimidin-nukleosidanaloger
NZ513402A (en) Novel nucleosides and oligonucleotide analogues
GB2332153A (en) Toy
BR9916772A (pt) Quinolinacarboxamidas como agentes antivirais
NZ324603A (en) Treatment of the CNS effects of HIV with VX-478, alone or in combination with AZT or 3TC
AP2001002207A0 (en) Antiviral nucleoside analogues.
EP1480982A4 (en) MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES
DK0494370T3 (da) Antivirale (phosphonomethoxy)methoxypurin/pyrimidinderivater
BG102647A (en) Acyclic nucleoside derivatives
FI944134L (fi) Virustenvastaisia nukleosidianalogeja
BR0111729A (pt) 1-aril-4-oxo-1,4-dihidro-3-quinolinacarboxamidas como agentes antivirais
DK1644389T3 (da) Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
GR3029454T3 (en) Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
DK1250337T3 (da) Substituerede homopiperidinylbenzimidazol-analoger som fundus-relaksanter
DK1068209T3 (da) Fremgangsmåde til fremstilling af purinderivater og deres mellemprodukter
FI953566L (fi) Tahdospironia tai sen analogeja sisältäviä koostumuksia
BG105964A (en) C(10) carbonate substituted taxanes and their use as antitumor agents
ES2167984T3 (es) Tabla de planchar.
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
MY128306A (en) Oct formulations
GB9506644D0 (en) Preparation of nucleoside analogues
FI972605A0 (fi) Myrsyraloesning med saenkt korroderande verkan
IL137426A0 (en) Joystick with a microphone
AU5825598A (en) Enhanced suppression of hiv-1 by the combination of cytidine nucleoside analogues and ctp synthase inhibitors
FI961105L (fi) Difluoristatoniviruksen vastaisia analogeja